Thymosin Alpha-1 + Thymalin
aka ta1thymalin
Immune Modulator
Mechanism
Vendor 'TA-1 Complex' blend combining Thymosin Alpha-1 (Zadaxin; approved in some countries for hepatitis B/C, not FDA-approved in the US) with Thymalin (a Russian calf-thymus polypeptide extract associated with the Khavinson research program). This blend is not clinically validated; no trials have studied the combination itself.
Identification
| Typical dose | Thymosin Alpha-1: 1.6 mg subcutaneous 2x/week (clinical) or 500 mcg/day; Thymalin: 5-10 mg IM for 10 consecutive days, 1-2 cycles/year |
|---|---|
| Half-life | Thymosin Alpha-1: ~2 hours (subcutaneous); Thymalin: ~30 minutes (dipeptide component), biological effects 24-72 hours |
Vendors selling Thymosin Alpha-1 + Thymalin
| Vendor | Size | Price | Listed purity | Trust |
|---|---|---|---|---|
| Skye Peptides | — | $89.00 | — | 90 |
Research
No citations on file yet.